This work was funded by the Intramural Research Program of the Center for Cancer Research, NCI and the Intramural AIDS Targeted Antiviral Program, NIH. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does ...
CD95/Fas is an apoptosis inducing death receptor. However, it also has multiple nonapoptotic activities that are tumorigenic. Chronic stimulation of CD95 on breast cancer cells can increase their cancer initiating capacity through activation of a type I
HIV-1 takes advantage of the cellular cytoskeleton at various steps in its replication cycle, most intriguingly is the involvement of the actin machinery during the entry process. However, knowledge is limited at other steps of the replication cycle and future work will be required to shed light...